Q-omics provides the consensus-scored GPR1-AS profile across patient tissues and cancer cell-line models. GPR1-AS expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in THYM. Among the 18 cancer types available for tumor–normal comparison, GPR1-AS is differentially expressed in 5, with the highest sampling consensus in KIRC. Additionally, GPR1-AS RNA expression shows 7,956 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight THYM, KIRC, and TGCT as cancer lineages where GPR1-AS shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for GPR1-AS — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes GPR1-AS survival associations across molecular data types. GPR1-AS RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible GPR1-AS RNA expression–survival associations across cancer types. High GPR1-AS expression shows unfavorable associations in THYM, KICH, KIRC, LGG and BRCA, but favorable associations in HNSC. The THYM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THYM as the clearest survival context for GPR1-AS RNA expression.
This table summarizes GPR1-AS tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for GPR1-AS. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. GPR1-AS shows lower tumor expression in KIRC, COAD and BLCA and higher tumor expression in HNSC and THCA. The KIRC box plot shows higher GPR1-AS RNA expression in normal versus tumor tissue (log2 FC = −0.015, t-test p = .014).
This table shows molecular features associated with GPR1-AS in patient tissues and cancer cell lines. In patient samples, GPR1-AS shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
